Adsorption of Blood Creatinine on a Heparin-Functionalized Surface of Copper-Based Metal-Organic Frameworks.

IF 1.2
Zhenyu Gui, Xiaoda Yang, Hao Chen, Jing Zhuang, Ping Lan
{"title":"Adsorption of Blood Creatinine on a Heparin-Functionalized Surface of Copper-Based Metal-Organic Frameworks.","authors":"Zhenyu Gui, Xiaoda Yang, Hao Chen, Jing Zhuang, Ping Lan","doi":"10.1002/1744-9987.70122","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Creatinine accumulation exacerbates outcomes in chronic kidney disease (CKD). To enhance creatinine removal and improve hemocompatibility, we developed heparin-functionalized copper-based metal-organic frameworks (CuMOFs-Hep).</p><p><strong>Methods: </strong>CuMOFs were heparinized via APTES bridging and characterized (XRD, SEM, FTIR, XPS, and zeta potential). Adsorption was evaluated in simulated CKD serum and was fitted with isotherm models. Whole-blood samples from patients/healthy donors were tested. Biosafety was assessed by Cu<sup>2+</sup> leaching and platelet assays.</p><p><strong>Results: </strong>Heparinization increased surface negative charge and raised the maximum capacity to 267.8 mg g<sup>-1</sup> (68.7% over pristine; Langmuir R <sup>2</sup> = 0.983). Adsorption kinetics studies indicate rapid clearance of creatinine, achieving a clearance rate of 65.9% within 30 min at 37°C and reaching 75.0% within 2 h. In patient blood (854.2 μmol/L), supernatant creatinine decreased to 163.2 μmol/L (80.9% removal). Cu<sup>2+</sup> leaching dropped to 0.214 ppm (-89.9%), with reduced platelet adhesion/activation.</p><p><strong>Conclusion: </strong>CuMOFs-Hep enables efficient, low-leaching creatinine adsorption in clinically relevant matrices, highlighting its promising potential as an efficient adsorbent for blood purification applications.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"363-370"},"PeriodicalIF":1.2000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/1744-9987.70122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Creatinine accumulation exacerbates outcomes in chronic kidney disease (CKD). To enhance creatinine removal and improve hemocompatibility, we developed heparin-functionalized copper-based metal-organic frameworks (CuMOFs-Hep).

Methods: CuMOFs were heparinized via APTES bridging and characterized (XRD, SEM, FTIR, XPS, and zeta potential). Adsorption was evaluated in simulated CKD serum and was fitted with isotherm models. Whole-blood samples from patients/healthy donors were tested. Biosafety was assessed by Cu2+ leaching and platelet assays.

Results: Heparinization increased surface negative charge and raised the maximum capacity to 267.8 mg g-1 (68.7% over pristine; Langmuir R 2 = 0.983). Adsorption kinetics studies indicate rapid clearance of creatinine, achieving a clearance rate of 65.9% within 30 min at 37°C and reaching 75.0% within 2 h. In patient blood (854.2 μmol/L), supernatant creatinine decreased to 163.2 μmol/L (80.9% removal). Cu2+ leaching dropped to 0.214 ppm (-89.9%), with reduced platelet adhesion/activation.

Conclusion: CuMOFs-Hep enables efficient, low-leaching creatinine adsorption in clinically relevant matrices, highlighting its promising potential as an efficient adsorbent for blood purification applications.

肝素功能化铜基金属有机骨架表面对血肌酐的吸附。
简介:肌酐积累加重慢性肾脏疾病(CKD)的预后。为了增强肌酐去除和改善血液相容性,我们开发了肝素功能化铜基金属有机框架(CuMOFs-Hep)。方法:采用APTES桥接法对cumof进行肝素化,并用XRD、SEM、FTIR、XPS和zeta电位对其进行表征。在模拟CKD血清中评估吸附作用,并采用等温模型拟合。对患者/健康献血者的全血样本进行检测。通过Cu2+浸出和血小板试验评价生物安全性。结果:肝素化使其表面负电荷增加,最大容量为267.8 mg g-1(比原液提高68.7%;Langmuir R2 = 0.983)。吸附动力学研究表明,肌酐的清除速度很快,在37℃下30分钟内达到65.9%的清除率,在2小时内达到75.0%。患者血(854.2 μmol/L)上清肌酐降至163.2 μmol/L(去除率80.9%)。Cu2+浸出率降至0.214 ppm(-89.9%),血小板粘附/活化降低。结论:CuMOFs-Hep能够在临床相关基质中高效、低浸出的吸附肌酐,突出了其作为血液净化应用的高效吸附剂的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书